A drug that has already been approved for treatment of tuberculosis could also be a powerful tool to combat another of the developing world's major diseases, researchers at the University of Dundee have found.
May 25, 2016
0
4
One form of the disease begins with large open sores that won't heal, then migrates to the nose and lips, rotting them away like a form of leprosy and leaving the victim badly disfigured.
Jun 7, 2018
1
1
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat ...
Feb 23, 2012
0
0
Coinfection with visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) has been observed in at least 35 countries on four continents and requires special case management. Currently, the World Health Organization ...
Jan 17, 2019
0
1
A new way to test for the parasite which causes the fatal disease leishmaniasis could help control its spread to humans and stop dogs being needlessly killed in parts of South America.
Jan 9, 2014
0
0
The protozoan disease visceral leishmaniasis (VL) has recently expanded to places where it had not previously been reported and has expanded its geographic distribution within countries where it was already endemic. Now, ...
Aug 29, 2019
0
2
A newly funded Tropical Medicine Research Center at The Ohio State University will study factors that drive transmission and spread of visceral leishmaniasis, a serious parasitic disease in Eastern Africa that is fatal without ...
Sep 7, 2022
0
6
With an estimated 500,000 human infections and 50,000 deaths annually, visceral leishmaniasis (VL) is the second most prevalent parasitic killer, behind malaria. Leishmania parasites are transmitted through the bite of phlebotomine ...
Aug 18, 2016
0
0
Visceral leishmaniasis is the second-deadliest parasitic disease after malaria. Each year, thousands fall victim among poor and marginalised populations in low-income countries. Filip Meheus is the first to detail the economic ...
Sep 16, 2013
0
0
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through ...
Nov 13, 2012
0
0
